thiazoles has been researched along with Liver Failure in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 18 (69.23) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parasrampuria, DA; Truitt, KE | 1 |
| Ackerson, L; Chan, KA; Everhart, JE; Gurwitz, JH; Hurley, JS; Martinson, B; Moseley, RH; Platt, R; Selby, JV; Terrault, N; Truman, A | 1 |
| Graham, DJ; Green, L; Nourjah, P; Senior, JR | 1 |
| Whitcomb, RW | 1 |
| Brunt, EM; Isley, WL; Neuschwander-Tetri, BA; Oki, JC; Phillips, NJ; Quiason, SG; Ramrakhiani, S | 1 |
| Miller, JL | 2 |
| Andrade, RJ; Bellot, V; Bermudez, F; Cárdenas, F; Fernandez, MC; Garcia-Escaño, MD; Gomez-Outes, A; Hervás, A; Lucena, MI; Martin-Vivaldi, R; Nogueras, F; Pelaez, G; Romero, M; Salmerón, J | 1 |
| Banner, BF; Bonkovsky, HL; Kohlroser, J; Mathai, J; Reichheld, J | 1 |
| Diamond, RH; Forman, LM; Simmons, DA | 1 |
| Boscia, J; Everitt, D; Freid, J | 1 |
| Adachi, H; Amano, S; Bamba, T; Fujiyama, Y; Fukano, M; Okabe, H; Sato, J; Yamamoto, K | 1 |
| Booth, AM; Caldwell, SH; Iezzoni, JC | 1 |
| Bass, NM; Chow, H; Davern, TJ; Freise, C; Lee, WM; Masharani, U; Murphy, EJ; Shakil, AO; Shick, L | 1 |
| Greene, HL | 1 |
| Isley, WL; Oki, JC | 2 |
| Fonseca, VA; Granda-Ayala, R; Lee, TR; Parulkar, AA; Pendergrass, ML | 1 |
| Gale, EA | 1 |
| Scheen, AJ | 1 |
| McMorran, M; Vu, D | 1 |
| Cohen, RI; Gouda, HE; Khan, A; Schwartz, J | 1 |
| Chase, MP; Yarze, JC | 1 |
| Freed, MI; Kreider, M; Lebovitz, HE | 1 |
6 review(s) available for thiazoles and Liver Failure
| Article | Year |
|---|---|
Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa.
Topics: Anticoagulants; Area Under Curve; Blood Coagulation; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Factor Xa Inhibitors; Half-Life; Humans; Liver Failure; Metabolic Clearance Rate; Protein Binding; Pyridines; Renal Insufficiency; Thiazoles | 2016 |
Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration.
Topics: Chromans; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Liver; Liver Failure; Male; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Nonhypoglycemic effects of thiazolidinediones.
Topics: Body Weight; Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Hemostasis; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Liver Failure; Oxidation-Reduction; Pancreas; Polycystic Ovary Syndrome; Risk Factors; Thiazoles | 2001 |
Lessons from the glitazones: a story of drug development.
Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Drug Approval; Drug Therapy, Combination; Europe; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; United States | 2001 |
Thiazolidinediones and liver toxicity.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Incidence; Liver; Liver Failure; Thiazoles; United States; United States Food and Drug Administration | 2001 |
Hepatotoxicity of thiazolidinediones.
Topics: Humans; Hypoglycemic Agents; Liver; Liver Failure; Liver Transplantation; Thiazoles; Thiazolidinediones | 2001 |
1 trial(s) available for thiazoles and Liver Failure
| Article | Year |
|---|---|
Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Liver Failure; Liver Function Tests; Male; Metformin; Middle Aged; Reference Values; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |
19 other study(ies) available for thiazoles and Liver Failure
| Article | Year |
|---|---|
Febuxostat: hepatic failure.
Topics: Febuxostat; Gout Suppressants; Humans; Liver Failure; Thiazoles; Xanthine Oxidase | 2013 |
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.
Topics: Acute Disease; Adult; Aged; Chemical and Drug Induced Liver Injury; Chromans; Cohort Studies; Female; Humans; Hypoglycemic Agents; Incidence; Insulin; Liver; Liver Failure; Male; Metformin; Middle Aged; Proportional Hazards Models; Severity of Illness Index; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Troglitazone-induced liver failure: a case study.
Topics: Age Distribution; Aged; Chemical and Drug Induced Liver Injury; Chromans; Chronic Disease; Confidence Intervals; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug and Narcotic Control; Female; Humans; Liver Failure; Liver Failure, Acute; Liver Function Tests; Male; Middle Aged; Odds Ratio; Probability; Registries; Risk Assessment; Severity of Illness Index; Sex Distribution; Survival Rate; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 2003 |
Update in endocrinology.
Topics: Chromans; Humans; Hypoglycemic Agents; Liver Failure; Neutropenia; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 1998 |
Troglitazone-induced hepatic failure leading to liver transplantation. A case report.
Topics: Chromans; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Liver Failure; Liver Transplantation; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
FDA drug-review, surveillance processes under scrutiny.
Topics: Chromans; Drug Approval; Humans; Hypoglycemic Agents; Liver Failure; Product Surveillance, Postmarketing; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 1999 |
Advisory panel hears contradictory evidence, backs keeping troglitazone on market.
Topics: Chromans; Consultants; Drug Monitoring; Humans; Hypoglycemic Agents; Liver Failure; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 1999 |
Diabetes drug Rezulin: take it, but take precautions.
Topics: Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Failure; Liver Function Tests; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.
Topics: Acute Disease; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Benzenesulfonates; Bilirubin; Chemical and Drug Induced Liver Injury; Female; Histamine H2 Antagonists; Humans; Liver; Liver Failure; Male; Middle Aged; Necrosis; Thiazoles | 1999 |
Hepatic failure in a patient taking rosiglitazone.
Topics: Aged; Combined Modality Therapy; Coronary Disease; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypoglycemic Agents; Ischemia; Liver; Liver Failure; Male; Monitoring, Physiologic; Pravastatin; Rosiglitazone; Thiazoles; Thiazolidinediones; Verapamil | 2000 |
Rosiglitazone and hepatic failure.
Topics: Coronary Disease; Humans; Hypoglycemic Agents; Ischemia; Liver; Liver Failure; Rosiglitazone; Thiazoles; Thiazolidinediones | 2000 |
Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: a case report with autopsy examination.
Topics: Chromans; Diabetes Mellitus, Type 2; Fatal Outcome; Female; Humans; Hypoglycemic Agents; Liver Failure; Middle Aged; Necrosis; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Troglitazone-associated hepatic failure.
Topics: Aged; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Fatal Outcome; Female; Hepatic Encephalopathy; Humans; Hyperlipidemias; Hypoglycemic Agents; Liver; Liver Failure; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group.
Topics: Chromans; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Liver; Liver Failure; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Drug recalls underscore safety concerns.
Topics: Arrhythmias, Cardiac; Chromans; Cisapride; Drug and Narcotic Control; Gastrointestinal Agents; Humans; Hypoglycemic Agents; Liver Failure; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 2000 |
Rosiglitazone and liver failure.
Topics: Humans; Liver Failure; Rosiglitazone; Thiazoles; Thiazolidinediones | 2000 |
Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
Topics: Aged; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Female; Hematologic Diseases; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |
Liver failure in a patient treated with long-term rosiglitazone therapy.
Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Humans; Hypoglycemic Agents; Liver Failure; Male; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |
Pioglitazone-associated fulminant hepatic failure.
Topics: Aged; Biopsy, Needle; Diabetes Mellitus, Type 2; Follow-Up Studies; Humans; Hypoglycemic Agents; Liver Failure; Liver Function Tests; Male; Pioglitazone; Risk Assessment; Thiazoles; Thiazolidinediones | 2002 |